Treatment of Nodular Basal Cell Carcinoma (BCC) With Imiquimod 5% Cream After Curettage

计划入组 15 人 · 首次发布于 2006 年 4 月 14 日

Photodynamic Therapy Associated With Sonodynamic Therapy for the Treatment of Nodular Basal Cell Carcinoma

计划入组 142 人 · 首次发布于 2026 年 2 月 2 日

Surgery Versus Combined Treatment With Curettage and Imiquimod for Nodular Basal Cell Carcinoma

计划入组 145 人 · 首次发布于 2014 年 9 月 17 日

small molecule therapeutic (basal cell carcinoma)

renal cell carcinoma program

basal insulin (Biodel)

Gamida Cell

Israel

GAMIDA CELL INC.

United States

CELL GENESYS INC.

United States

Medicus Pharma Completes Phase 2 Enrollment for Novel Microneedle Basal Cell Carcinoma Treatment

AiViva Biopharma Receives FDA Clearance to Test AIV001 in Facial Skin

Medicus Pharma Bolsters Leadership Team, Advances D-MNA for Skin Cancer